Martha Aguirre, former El Paso ISD interim superintendent, resigns as CFO as district finds ‘key financial challenges’
May 8, 2026 - 01:31
Aguirre stepped down from the CFO role this week. She had previously led the district as interim superintendent before moving into the top financial position. The announcement did not provide specific details about the nature of the financial issues found, but district officials said the review raised serious concerns about EPISD's overall financial health.
The resignation comes at a time when the district is already facing scrutiny over its budget and spending practices. School board members indicated that a deeper investigation into the district's finances is likely. Aguirre's departure marks the second major leadership change in recent months for El Paso ISD, which has been working to stabilize its administration and address long-standing fiscal problems. The district has not yet named an interim replacement for the CFO position.
MORE NEWS
May 7, 2026 - 23:26
Stock market today: Dow, S&P 500, Nasdaq stall as crude oil steadies in wait for Iran-US deal updateU.S. stock indexes took a breather on Tuesday, with the Dow, S&P 500, and Nasdaq all stalling after a recent run of gains. The pause came as crude oil prices steadied, with traders waiting for the...
May 7, 2026 - 11:15
Australian Banks Warned as Financial Pressure Mounts: "These Are Tough Times"Financial hardship support services across Australia are reporting their busiest start to any year on record, as rising living costs and interest rate hikes push more households into distress....
May 6, 2026 - 19:57
Justice Department agrees to return Rep. Andy Ogles' phone, signaling end of campaign finance probeWASHINGTON (AP) - The Justice Department has agreed to return U.S. Representative Andy Ogles` personal cellphone, a move that signals the end of a campaign finance investigation that began under...
May 6, 2026 - 04:02
AtriCure Reports First Quarter 2026 Financial ResultsMASON, Ohio, May 5, 2026 -- AtriCure, a company focused on surgical treatments for atrial fibrillation and related conditions, reported its financial results for the first quarter of 2026. The...